1 / 14

HIV

Rapid Progression to AIDS in HIV+ Individuals with a Structural Variant of the Chemokine Receptor CX3CR1 .

baina
Télécharger la présentation

HIV

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rapid Progression to AIDS in HIV+ Individuals with a Structural Variant of the Chemokine Receptor CX3CR1 Sophie Faure, 1 Laurence Meyer, 2 Dominique Costagliola, 3 Céline Vaneensberghe, 1 Emmanuelle Genin, 4 Brigitte Autran, 1 French ALT and IMMUNOCO Study Groups, Jean-François Delfraissy, 5 SEROCO Study Group, David H. McDermott, 6 Philip M. Murphy, 6 Patrice Debré, 1 Ioannis Théodorou, 1* Christophe Combadière 1, 6, 7

  2. HIV • Virus responsible for AIDS • Enters cells in vitro via CD4 • Mutation in coreceptors and chemokine ligands suggest delay in progression

  3. Chemokines • Chemical mediators • Stimulate movement and migration of white blood cells (helpful in fighting off infection)

  4. Focus: CX3CR1 • HIV coreceptor • Leukocyte chemotactic and adhesion receptor for the chemokine fractalkine • Limited interaction with tested HIV envelopes

  5. Fractalkine • Produced by monocytes and dendritic cells • Results in the recruitment of T cells • Contains special adhesion properties • Reinforces cell contact • Efficiently blocks the HIV coreceptor activity of CX3CR1

  6. Investigation • Whether CX3CR1 plays a role in regulating HIV progression

  7. Screening of CX3CR1 Coding Sequence • Screened for mutations by way of a single-stranded conformation polymorphism (SSCP) technique

  8. 4 nonsynonymous A-G subst’n: Thr57 changed to Ala (T57A) G-A subst’n: Val122 changed to Ile (V122I) G-A subst’n: Val240 changed to Ile (V249I) C-T subst’n: Thr280 changed to Met (T280M) 1 nonsynonymous Codon 255: G-A subst’n 5 Single Nucleotide Polymorphisms Identified

  9. Results • 25.7% V249I and 13.5% T280M found among the uninfected population

  10. Study of V249I & T280M • Analyzed via restriction fragment length polymorphism-based method • Study of 565 people among 3 cohorts • IMMUNOCO - intermediate progression • ALT – asymptomatic long term progression • SEROCO – known date of seroconversion

  11. V249 I G/G - homozygous w.t. A/A – homozygous mutation A/A – homozygous mutation A/A – homozygous mutation G/A - heterozygous G/A - heterozygous T280M C/C – homozygous w.t. C/C – homozygous w.t. T/T – homozygous mutation C/T - heterozygous C/C – homozygous w.t. C/T - heterozygous 6 Genotypes observed

  12. ALT IMMUNOCO SEROCO UNINFECTED 3 Haplotypes Observed

  13. Effect of CX3CR1 Variants on HIV Progression

  14. Findings • CX3CR1 is polymorphic in the Caucasian population • I249 M280 associated with accelerated HIV disease • Because CX3CR1 is a coreceptor for HIV, it is a possible target for therapeutic intervention

More Related